KeyBanc lowered the firm’s price target on Alcon (ALC) to $91 from $98 to reflect challenging second half of 2025 setup, while keeping an Overweight rating on the shares. The firm continues to view Alcon as a key long-term idea but believes there may be limited upside to its second half of 2025 guidance.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALC:
- Staar Surgical shareholder issues letter opposing Alcon acquisition
- Staar Surgical sale faces growing opposition from Broadwood
- Activist Jana Partners Takes Stake in Cooper Companies, Presses for Strategic Review
- Broadwood urges shareholders vote ‘AGAINST’ acquisition of STAAR by Alcon
- Broadwood: Proxy advisory firms recommend Staar shareholders vote against sale